Honing Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Liquidation

Honing Biosciences General Information

Description

Developer of cell-based therapies designed to treat cancer and other chronic diseases. The company's therapies help to develop new classes of tunable cell therapeutics to control the delivery of proteins in patients by increasing the efficacy and limiting the harmful drawbacks of previous generations of treatments, enabling clinicians to focus on improving medicine by re-engaging the body's immune system to treat cancer.

Contact Information

Website
www.honing-biosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 29 Rue du FG Saint Jacques
  • 75014 Paris
  • France
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 29 Rue du FG Saint Jacques
  • 75014 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Honing Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 09-May-2023 Completed Bankruptcy: Liquidation
4. Secondary Transaction - Private 01-Mar-2023 Completed Generating Revenue
3. Early Stage VC 07-Jul-2020 Completed Generating Revenue
2. Seed Round 25-Sep-2018 $583K $583K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Honing Biosciences’s complete valuation and funding history, request access »

Honing Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
ADP Seed
To view Honing Biosciences’s complete cap table history, request access »

Honing Biosciences Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Honing Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4277934-A1 Her2 single domain antibodies variants and cars thereof Pending 14-Jan-2021
US-20240317890-A1 Her2 single domain antibodies variants and cars thereof Pending 14-Jan-2021
WO-2022152862-A1 Her2 single domain antibodies variants and cars thereof Inactive 14-Jan-2021
JP-2024505428-A Her2 single domain antibody variants and their cars Pending 14-Jan-2021
JP-2023554542-A Means and methods for controlling intracellular transport of secreted or cell membrane-anchored proteins of interest Pending 13-Nov-2020 C07K14/36
To view Honing Biosciences’s complete patent history, request access »

Ready to get started?

Request a free trial

Honing Biosciences FAQs

  • When was Honing Biosciences founded?

    Honing Biosciences was founded in 2018.

  • Where is Honing Biosciences headquartered?

    Honing Biosciences is headquartered in Paris, France.

  • What industry is Honing Biosciences in?

    Honing Biosciences’s primary industry is Biotechnology.

  • Is Honing Biosciences a private or public company?

    Honing Biosciences is a Private company.

  • What is Honing Biosciences’s current revenue?

    The current revenue for Honing Biosciences is .

  • How much funding has Honing Biosciences raised over time?

    Honing Biosciences has raised $2.83M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process